BioAge Labs, Inc. (BIOA)

BioAge Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	188.89	354.35	24.96	27.64
Short-Term Investments	92.21	-	-	-
Cash & Short-Term Investments	281.1	354.35	24.96	27.64
Cash Growth	-20.67%	1319.84%	-9.72%	-
Accounts Receivable	0.77	-	-	-
Other Current Assets	4.93	2.75	0.35	0.39
Total Current Assets	286.79	357.1	25.31	28.03
Net Property, Plant & Equipment	3.75	0.79	0.52	0.37
Long-Term Investments	4.13	0.1	0.1	-
Other Long-Term Assets	0.22	0.24	-	0.03
Total Assets	294.89	358.23	25.92	28.43
Accounts Payable	2.67	2	1.87	2.26
Accrued Expenses	8.48	11.75	7.94	3.38
Short-Term Debt	-	-	20.67	-
Current Portion of Long-Term Debt	2.65	6	6	0.17
Current Portion of Leases	0.58	0.2	0.19	0.05
Unearned Revenue	5.75	7.83	3.31	-
Other Current Liabilities	-	-	18.18	-
Total Current Liabilities	20.14	27.78	58.17	5.86
Long-Term Debt	-	2.5	8.2	2.25
Long-Term Leases	2.33	-	-	-
Other Long-Term Liabilities	0.37	4.83	0.23	0.15
Total Long-Term Liabilities	2.7	7.33	8.43	2.41
Total Liabilities	22.84	35.11	66.6	8.27
Additional Paid-in Capital	605.19	575.69	8.14	5.12
Accumulated Other Comprehensive Income	0.28	0.25	0.16	0.17
Retained Earnings	-333.42	-252.81	-181.7	-117.85
Total Common Shareholders' Equity	272.05	323.13	-173.4	-112.56
Minority Interest	-	-	132.72	132.72
Shareholders' Equity	272.05	323.13	-40.67	20.16
Total Liabilities & Equity	294.89	358.23	25.92	28.43
Total Debt	5.56	8.7	35.07	2.47
Net Cash (Debt)	275.54	345.65	-10.11	25.18
Net Cash Growth	-20.28%	-	-	-
Net Cash Per Share	7.67	32.22	-6.04	15.06
Book Value	272.05	323.13	-173.4	-112.56
Book Value Per Share	7.57	30.12	-103.66	-67.33
Tangible Book Value	272.05	323.13	-173.4	-112.56
Tangible Book Value Per Share	7.57	30.12	-103.66	-67.33

Updated Mar 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q